Cargando…

Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression

A widely accepted concept in perinatal medicine is that boys are more susceptible than girls to complications of prematurity. However, whether this ‘male disadvantage of prematurity’ also involves persistent patent ductus arteriosus (PDA) has been scarcely investigated. Our aim was to conduct a syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges-Lujan, Moreyba, Gonzalez-Luis, Gema E., Roosen, Tom, Huizing, Maurice J., Villamor, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321725/
https://www.ncbi.nlm.nih.gov/pubmed/35887640
http://dx.doi.org/10.3390/jpm12071143
_version_ 1784756118346530816
author Borges-Lujan, Moreyba
Gonzalez-Luis, Gema E.
Roosen, Tom
Huizing, Maurice J.
Villamor, Eduardo
author_facet Borges-Lujan, Moreyba
Gonzalez-Luis, Gema E.
Roosen, Tom
Huizing, Maurice J.
Villamor, Eduardo
author_sort Borges-Lujan, Moreyba
collection PubMed
description A widely accepted concept in perinatal medicine is that boys are more susceptible than girls to complications of prematurity. However, whether this ‘male disadvantage of prematurity’ also involves persistent patent ductus arteriosus (PDA) has been scarcely investigated. Our aim was to conduct a systematic review and meta-analysis on studies addressing sex differences in the risk of developing PDA among preterm infants. We also investigated whether the response to pharmacological treatment of PDA differs between boys and girls. PubMed/Medline and Embase databases were searched. The random-effects male/female risk ratio (RR) and 95% confidence interval (CI) were calculated. We included 146 studies (357,781 infants). Meta-analysis could not demonstrate sex differences in risk of developing any PDA (37 studies, RR 1.03, 95% CI 0.97 to 1.08), hemodynamically significant PDA (81 studies, RR 1.00, 95% CI 0.97 to 1.02), or in the rate of response to pharmacological treatment (45 studies, RR 1.01, 95% CI 0.98 to 1.04). Subgroup analysis and meta-regression showed that the absence of sex differences was maintained over the years and in different geographic settings. In conclusion, both the incidence of PDA in preterm infants and the response rate to pharmacological treatment of PDA are not different between preterm boys and girls.
format Online
Article
Text
id pubmed-9321725
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93217252022-07-27 Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression Borges-Lujan, Moreyba Gonzalez-Luis, Gema E. Roosen, Tom Huizing, Maurice J. Villamor, Eduardo J Pers Med Systematic Review A widely accepted concept in perinatal medicine is that boys are more susceptible than girls to complications of prematurity. However, whether this ‘male disadvantage of prematurity’ also involves persistent patent ductus arteriosus (PDA) has been scarcely investigated. Our aim was to conduct a systematic review and meta-analysis on studies addressing sex differences in the risk of developing PDA among preterm infants. We also investigated whether the response to pharmacological treatment of PDA differs between boys and girls. PubMed/Medline and Embase databases were searched. The random-effects male/female risk ratio (RR) and 95% confidence interval (CI) were calculated. We included 146 studies (357,781 infants). Meta-analysis could not demonstrate sex differences in risk of developing any PDA (37 studies, RR 1.03, 95% CI 0.97 to 1.08), hemodynamically significant PDA (81 studies, RR 1.00, 95% CI 0.97 to 1.02), or in the rate of response to pharmacological treatment (45 studies, RR 1.01, 95% CI 0.98 to 1.04). Subgroup analysis and meta-regression showed that the absence of sex differences was maintained over the years and in different geographic settings. In conclusion, both the incidence of PDA in preterm infants and the response rate to pharmacological treatment of PDA are not different between preterm boys and girls. MDPI 2022-07-14 /pmc/articles/PMC9321725/ /pubmed/35887640 http://dx.doi.org/10.3390/jpm12071143 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Borges-Lujan, Moreyba
Gonzalez-Luis, Gema E.
Roosen, Tom
Huizing, Maurice J.
Villamor, Eduardo
Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression
title Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression
title_full Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression
title_fullStr Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression
title_full_unstemmed Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression
title_short Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression
title_sort sex differences in patent ductus arteriosus incidence and response to pharmacological treatment in preterm infants: a systematic review, meta-analysis and meta-regression
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321725/
https://www.ncbi.nlm.nih.gov/pubmed/35887640
http://dx.doi.org/10.3390/jpm12071143
work_keys_str_mv AT borgeslujanmoreyba sexdifferencesinpatentductusarteriosusincidenceandresponsetopharmacologicaltreatmentinpreterminfantsasystematicreviewmetaanalysisandmetaregression
AT gonzalezluisgemae sexdifferencesinpatentductusarteriosusincidenceandresponsetopharmacologicaltreatmentinpreterminfantsasystematicreviewmetaanalysisandmetaregression
AT roosentom sexdifferencesinpatentductusarteriosusincidenceandresponsetopharmacologicaltreatmentinpreterminfantsasystematicreviewmetaanalysisandmetaregression
AT huizingmauricej sexdifferencesinpatentductusarteriosusincidenceandresponsetopharmacologicaltreatmentinpreterminfantsasystematicreviewmetaanalysisandmetaregression
AT villamoreduardo sexdifferencesinpatentductusarteriosusincidenceandresponsetopharmacologicaltreatmentinpreterminfantsasystematicreviewmetaanalysisandmetaregression